Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 09, 2019; 92 (15 Supplement) May 5, 2019

A First in Human Study of PBT434, a Novel Small Molecule Inhibitor of α-Synuclein Aggregation (S4.001)

David Stamler, Margaret Bradbury, Cynthia Wong, Elliot Offman
First published April 16, 2019,
David Stamler
1Prana Biotechnology Newark CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret Bradbury
1Prana Biotechnology Newark CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cynthia Wong
1Prana Biotechnology Newark CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elliot Offman
2Certara Strategic Consulting Toronto ON Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
A First in Human Study of PBT434, a Novel Small Molecule Inhibitor of α-Synuclein Aggregation (S4.001)
David Stamler, Margaret Bradbury, Cynthia Wong, Elliot Offman
Neurology Apr 2019, 92 (15 Supplement) S4.001;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Article Information

vol. 92 no. 15 Supplement S4.001

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 16, 2019.

Copyright & Usage: 
© 2019

Author Disclosures

    1. David Stamler1,
    2. Margaret Bradbury1,
    3. Cynthia Wong1 and
    4. Elliot Offman2
  1. David Stamler1,
  2. Margaret Bradbury1,
  3. Cynthia Wong1 and
  4. Elliot Offman2
  1. 1Prana Biotechnology Newark CA United States
  2. 2Certara Strategic Consulting Toronto ON Canada

Article usage

Article usage: April 2019 to April 2022

AbstractFullPdfSource
Apr 2019900Highwire
May 20194600Highwire
Jun 20199800Highwire
Jul 201911000Highwire
Aug 201911200Highwire
Sep 201910100Highwire
Oct 20199900Highwire
Nov 20197500Highwire
Dec 20194200Highwire
Jan 20208500Highwire
Feb 20208400Highwire
Mar 20208900Highwire
Apr 20205600Highwire
May 20207400Highwire
Jun 20205300Highwire
Jul 20208900Highwire
Aug 20208000Highwire
Sep 20206400Highwire
Oct 20204000Highwire
Nov 20205800Highwire
Dec 20206200Highwire
Jan 20216400Highwire
Feb 20216300Highwire
Mar 20214900Highwire
Apr 20216000Highwire
May 20212200Highwire
Jun 20214400Highwire
Jul 20214400Highwire
Aug 20213900Highwire
Sep 20214900Highwire
Oct 20215000Highwire
Nov 20213100Highwire
Dec 20212400Highwire
Jan 20224500Highwire
Feb 20222700Highwire
Mar 20224300Highwire
Apr 20222300Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 98 (21)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise